Amgen Inc (NASDAQ:AMGN) on 08/02/2019 declared a dividend of $ 1.4500 per share payable on September 06, 2019 to shareholders of record as of August 15, 2019.

Amgen Inc (NASDAQ:AMGN) has paid dividends since 1997, has a current dividend yield of 3.1182796955% and has increased its dividends for 7 successive years.

Amgen Inc's market cap is $ 111,544,386,000 and has a PE ratio of 14.74. The stock price closed yesterday at $ 186.00 and has a 52 week low/high of $ 166.30 and $ 210.19.

Amgen is a biotechnology company that discovers, develops, manufactures and delivers human therapeutics. Co. focuses its research and development on human therapeutics for the treatment of illness. Co.'s principal products include Enbrel®, Neulasta®, Prolia®, Aranesp®, XGEVA®, Sensipar®/Mimpara®, and EPOGEN®. In addition, Co. also markets several other products, including KYPROLIS® (carfilzomib), Nplate® (romiplostim), Vectibix® (panitumumab), Repatha® (evolocumab), NEUPOGEN® (filgrastim), Parsabiv®, BLINCYTO® (blinatumomab), Aimovig® (erenumab-aooe), IMLYGIC® (talimogene laherparepvec), Corlanor® (ivabradine), KANJINTITM (biosimilar trastuzumab) and AMGEVITATM (biosimilar adalimumab).

For more information on Amgen Inc click here.